Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

被引：190
|
作者：
Antonioli, E [1 ]
Guglielmelli, P [1 ]
Pancrazzi, A [1 ]
Bogani, C [1 ]
Verrucci, M [1 ]
Ponziani, V [1 ]
Longo, G [1 ]
Bosi, A [1 ]
Vannucchi, AM [1 ]
机构：
[1] Univ Florence, Dept Hematol, Azienda Osped, I-50134 Florence, Italy
来源：
LEUKEMIA | 2005年 / 19卷 / 10期
关键词：
D O I：
10.1038/sj.leu.2403902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1847 / 1849
页数：4
相关论文
共 50 条
  • [41] The JAK2 V617F mutation in patients with anaemia
    Langabeer, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
  • [42] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [43] Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia:: measuring the uncertain
    Ziakas, Panayiotis D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (09): : 1412 - 1414
  • [44] A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate
    Ebisawa, Kazutoshi
    Masamoto, Yosuke
    Yagi, Koichi
    Kurokawa, Mineo
    ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2551 - 2552
  • [45] Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia
    Abdelghani, Maroua
    Hammami, Haifa
    Zidi, Wiem
    Amouri, Hassiba
    Othmen, Hind Ben Hadj
    Farrah, Ahlem
    Menif, Samia
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (08)
  • [46] A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate
    Kazutoshi Ebisawa
    Yosuke Masamoto
    Koichi Yagi
    Mineo Kurokawa
    Annals of Hematology, 2022, 101 : 2551 - 2552
  • [47] INFLUENCE OF THE CARDIOVASCULAR RISK FACTORS AND V617F JAK2 MUTATION IN THE THROMBOTIC RISK IN YOUNG PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Gomez Virginia, Escamilla
    Cuadrado Isabel, Montero
    Maria Angeles, Munoz
    Campos Jose, Gonzalez
    Francisco Jose, Marquez Malaver
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2016, 101 : 155 - 155
  • [48] Leukocyte alkaline phosphatase expression predicts the JAK2 V617F mutation status in polycythemia vera and essential thrombocythemia
    Rambaldi, A.
    Guerini, V.
    Carobbio, A.
    Salvi, A.
    Spinelli, O.
    Delaini, F.
    Finazzi, G.
    Barbui, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 414 - 415
  • [49] INCREASED RISK OF SPLANCHNIC OR CEREBRAL VENOUS THROMBOSIS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA CARRYING THE JAK2 V617F MUTATION
    De Stefano, V.
    Rossi, E.
    Za, T.
    Ciminello, A.
    Betti, S.
    Luzzi, C.
    De Ritis, D.
    Chiusolo, P.
    Leone, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 410 - 410
  • [50] Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation
    Drofenik, Ajda Anzic
    Vrtovec, Matjaz
    Mijovski, Mojca Bozic
    Sever, Matjaz
    Zupan, Irena Preloznik
    Kejzar, Natasa
    Blinc, Ales
    ATHEROSCLEROSIS, 2020, 296 : 25 - 31
12345